Regulatory oversight and safety of probiotic use.
Venugopalan
Veena
V
University of Southern California, Los Angeles, California 90033, USA.
Shriner
Kimberly A
KA
Wong-Beringer
Annie
A
D000075202:Contraindications; D016638:Critical Illness; D019587:Dietary Supplements; D004761:Enterocolitis, Pseudomembranous / Q000517:prevention & control; D016469:Fungemia / Q000382:microbiology; D006801:Humans; D007880:Legislation, Drug; D019936:Probiotics / Q000009:adverse effects* / Q000627:therapeutic use*; D012440:Saccharomyces / Q000502:physiology; D055502:Secondary Prevention; D014481:United States; D014486:United States Food and Drug Administration